Nouvelle déclaration d'incident
No de la demande: 2021-3144
Numéro de référence du titulaire d'homologation: USA-BAYERBAH-2021-US0021207 (Report 702242)
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer inc
Adresse: 2920 Matheson Blvd
Ville: Mississaugua
État: ON
Pays: Canada
Code postal /Zip: L4W 5R6
Incident chez un animal domestique
Pays: UNITED STATES
État: NEW YORK
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 11556-155
Nom du produit: Seresto cat
Autre (préciser)
COLLAROui
Autres unités: COLLAR
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair
1
Homme
11
Inconnu
Cutanée
>1 mo <= 6 mos / > 1 mois < = 6 mois
>1 mo <=2 mos / > 1 mois < = 2 mois
Système
Unknown / Inconnu
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On approximately 01-Jul-2018, the cat developed increased hunger and unspecified weight loss. On approximately 15-Jul-2018, the cat developed lethargy. On approximately 01-Aug-2018, the cat was laying in the sink (behavioral changes NOS). The cat was bathed with an unspecified flea shampoo and live fleas were visualized on the cat. On approximately 15-Aug-2018, the cat was laying in the litter box (behavioral changes NOS) and exhibited impaired consciousness. The cat was evaluated by the veterinarian but died before any treatments could be performed. The intent of the call was not to report the death of the animal but rather to inquire about product use in general. No further information is expected. This case is closed
Mort
O - Unclassifiable/unassessable SLEE/fleas. Reported increased hunger, unspecified weight loss, lethargy, behavioural signs are very unspecific and may have numerous other causes. Presence of fleas is not necessarily a sign of inefficacy. Product is not a repellent. Fleas have to be on the animal to come into contact with the product to be killed. Fleas were reported after a flea-free time. Sudden appearance of fleas after flea-free time suggests re-infestation with fleas from environment (e.g. other untreated pets, wildlife). This may lead to new establishment of a flea population in pets environment requiring several weeks of treatment to disappear. Further, potential contributing factors e.g. high risk area or high infestation pressure were not clarified. Reported impaired consciousness and death are not expected following appropriate topical product application as inconsistent with products pharmacological profile. Oral exposure to the collar is not expected to cause serious signs either. An overdose of 5 collars around the neck was investigated in adult cats and dogs for an 8 months period and in 10 week old kittens and 7 week old puppies for a 6 months period without causing serious signs. This is supported by the extremely low systemic exposure with imidacloprid and flumethrin, particularly during the first week after application and also thereafter. The geriatric cat had a concomitant condition of feline Immunodeficiency virus which may have contributed to the signs. Moreover, the intent of the call was not to report the death of the animal but rather to inquire about product use in general. Time to onset is long. Overall due to limited information regarding Veterinary diagnosis and necropsy, case is considered unassessable.